Uniqure NV at RBC Capital Markets Global Healthcare Conference (Virtual) Transcript
Great. Hello, everybody, and thank you for dialing in. My name is Luca Issi. I'm a senior biotech analyst here at RBC Capital Market. And today is a great privilege to have Matt Kapusta, CEO of UniQure, for a fireside chat. Matt, thanks so much for joining us.
Questions & Answers
And maybe let's start with hemophilia B here. Before we go into the specifics, we'd love to pick your brain here at high level on the programs and maybe some of the recent progress that you have made, and then we'll dive into specifics. And thanks again for joining, Matt.
No, really appreciate the invitation, Luca. Thanks for having us. Yes. So I think the most recent news is that we closed our landmark collaboration with CSL, who's going to be our global commercial partner for EtranaDez. So we're really excited about that,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |